Dietary Phytoestrogen, Serum Enterolactone and Risk of Prostate Cancer: The Cancer Prostate Sweden Study (Sweden)
- 1 March 2006
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 17 (2) , 169-180
- https://doi.org/10.1007/s10552-005-0342-2
Abstract
Based on evidence that phytoestrogens may protect against prostate cancer, we evaluated the associations between serum enterolactone concentration or dietary phytoestrogen intake and risk of prostate cancer.Keywords
This publication has 45 references indexed in Scilit:
- Alcohol drinking and risk of localized versus advanced and sporadic versus familial prostate cancer in SwedenCancer Causes & Control, 2005
- Dietary Factors and Risk of Non-Hodgkin Lymphoma in Men and WomenCancer Epidemiology, Biomarkers & Prevention, 2005
- Prospective study of plasma enterolactone and prostate cancer risk (Sweden)Cancer Causes & Control, 2004
- Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studiesBJU International, 2004
- Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancerBritish Journal of Nutrition, 2004
- Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancerEuropean Journal Of Cancer Prevention, 2003
- Phyto-oestrogen database of foods and average intake in FinlandBritish Journal of Nutrition, 2003
- Circulating enterolactone and prostate cancer risk: A Nordic nested case‐control studyInternational Journal of Cancer, 2002
- Phytoestrogen intake and prostate cancer: A case‐control study using a new databaseNutrition and Cancer, 1999
- Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG)Journal of Steroid Biochemistry, 1987